Hong Kong Stock Announcement Highlights | SSY GROUP Reports Q1 Profit Attributable to Shareholders of Approximately HK$171 Million, Up 1.6% Year-on-Year

Stock News05-05

Significant Developments: HENLIUS (02696) has obtained approval in Japan to conduct an international multi-center Phase 2/3 clinical trial for its drug HLX43, either as a monotherapy or in combination with PIMURUTAMAB HLX07, for the treatment of advanced squamous non-small cell lung cancer. EDDING GENOR (06998) announced that Candid Therapeutics has been acquired by UCB, with an upfront payment of US$2 billion. ISP GLOBAL (08487) is currently in discussions with potential large-scale partners in the food and beverage industry regarding cooperation within mainland China. SWANGCHAICHUAN (02321) has entered into a joint venture agreement with HCT for the financing, development, and operation of a sheep-derived nano-collagen production facility in Collie, Western Australia.

Operating Performance: SSY GROUP (02005) reported a profit attributable to shareholders of approximately HK$171 million for the first quarter, representing a 1.6% increase compared to the same period last year. Budweiser Brewing Company APAC (01876) released its first-quarter results, with a profit attributable to equity holders of US$226 million, down 3.42% year-on-year. XPENG Group-W (09868) delivered 31,011 new vehicles in April, marking a 13% increase from the previous month.

Share Buybacks: Netease Cloud Music (09899) repurchased 127,000 shares on May 4 for HK$14.9995 million. J&T Express-W (01519) bought back 196,800 shares on May 4 at a cost of HK$19.5037 million. AIA Group (01299) repurchased 70,300 shares on May 4 for HK$60.994 million. COSCO SHIPPING Holdings (01919) repurchased 188,400 shares on May 4, spending HK$27.6214 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment